Study About Efficacy and Safety to Treat Multi-System-Atrophy
Double-Blind, Randomised, Two-Armed Study for the Evaluation of Efficacy and Safety of Minocycline for Treatment
Sponsor: Competence Network on Parkinson's Disease
A PHASE3 clinical study on Minocycline and Multi-System-Atrophy, this trial is completed. The trial is conducted by Competence Network on Parkinson's Disease and has accumulated 5 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Dec 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Competence Network on Parkinson's Disease
- European MSA-Study Group
- Federal Institute of Education and Sience
- German Parkinson Study Group (GPS)
For direct contact, visit the study record on ClinicalTrials.gov .